Alfred Krebs

Clínica Alemana

Papers

1

Total Citations

7

H-Index

1

About

Alfred Krebs is a leading urologic oncologist whose research focuses on advancing surgical techniques for renal cell carcinoma, particularly through robot-assisted partial nephrectomy. His most-cited work, a 2022 study on long-term oncological and functional outcomes after robot-assisted partial nephrectomy for clinically localized renal cell carcinoma, has garnered 7 citations, underscoring its relevance in refining minimally invasive kidney cancer management. Krebs’ contributions center on balancing cancer control with renal function preservation, a critical challenge in nephron-sparing surgery. By analyzing postoperative outcomes, he has helped validate the efficacy of robotic approaches in reducing complications while maintaining oncological safety. His research is instrumental for surgeons and trainees seeking evidence-based guidance on optimizing patient recovery and quality of life post-surgery. Krebs’ work bridges clinical practice and emerging technologies, offering actionable insights for improving surgical precision. For students and researchers in urologic oncology, his studies provide a foundational understanding of how robotic platforms can enhance outcomes in localized renal tumors, positioning him as a key voice in the evolution of minimally invasive urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Long-Term Oncological and Functional Outcomes After Robot-Assisted Partial Nephrectomy for Clinically Localized Renal Cell Carcinoma
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Clínica Alemana

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago